Randomized, controlled, participant‐ and rater‐blind trial of pharmacogenomic test‐guided treatment versus treatment as usual for major depressive disorder-Reference-Cited by-同舟云学术

Randomized, controlled, participant‐ and rater‐blind trial of pharmacogenomic test‐guided treatment versus treatment as usual for major depressive disorder

Published:2020-05-07 Issue:9 Volume:37 Page:834-841
ISSN:1091-4269
Container-title:Depression and Anxiety
language:en
Short-container-title:Depression and Anxiety

Author:

Perlis Roy H.¹^ORCID,Dowd Daniel²,Fava Maurizio¹,Lencz Todd³,Krause David S.²^ORCID

Affiliation:

1. Department of Psychiatry and Division of Clinical Research Massachusetts General Hospital and Harvard Medical School Boston Massachusetts

2. Clinical Research & Development and Medical Affairs Genomind, Inc. King of Prussia Pennsylvania

3. Department of Psychiatry Zucker School of Medicine at Hofstra/Northwell Hempstead New York

Funder

Genomind, Inc.

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Psychology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/da.23029

Reference15 articles.

1. Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials

2. Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools

3. Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility

4. The role of pharmacogenomics in adverse drug reactions

5. RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ)

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug metabolizing enzymes pharmacogenetic variation-informed antidepressant therapy approach for common mental disorders: A systematic review and meta-analysis;Journal of Affective Disorders;2024-12

2. Implementation and Evaluation Strategies for Pharmacogenetic Testing in Hospital Settings: A Scoping Review;Therapeutic Drug Monitoring;2024-09-11

3. Efficacy and safety of pharmacogenomic-guided antidepressant prescribing in patients with depression: an umbrella review and updated meta-analysis;Frontiers in Psychiatry;2024-07-11

4. Pharmacogenomic Clinical Support Tools for the Treatment of Depression;American Journal of Psychiatry;2024-07-01

5. Pharmacogenomic Testing to Guide Treatment of Major Depressive Disorder: A Systematic Review;Current Treatment Options in Psychiatry;2024-05-31